Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-14-059069
Filing Date
2014-09-22
Accepted
2014-09-22 18:58:21
Documents
1
Period of Report
2014-09-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3214
  Complete submission text file 0001209191-14-059069.txt   4769
Mailing Address
Business Address 10590 W OCEAN AIR DR STE 200 SAN DIEGO CA 92130 8583145700
PROEHL GERALD T (Reporting) CIK: 0001279191 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36292 | Film No.: 141114841
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3366 N. TORREY PINES COURT SUITE 225 LA JOLLA CA 92037
Business Address 3366 N. TORREY PINES COURT SUITE 225 LA JOLLA CA 92037 (858) 558-2400
Auspex Pharmaceuticals, Inc. (Issuer) CIK: 0001454189 (see all company filings)

EIN.: 954862842 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations